More importantly, these circulating CD4+ T cells in T1D patients produce IL-17 when they are activated by β-cell autoantigens including proinsulin, insulinoma-associated protein, and GAD65 peptides [24]. This evidence concerns the gene CD4 and type 1 diabetes mellitus.